Skip Nav Destination
Issues
15 January 2000
ISSN 0022-1767
EISSN 1550-6606
CUTTING EDGE
Cutting Edge: Cationic Antimicrobial Peptides Block the Binding of Lipopolysaccharide (LPS) to LPS Binding Protein1
J Immunol (2000) 164 (2): 549–553.
Cutting Edge: Preferentially the R-Stereoisomer of the Mycoplasmal Lipopeptide Macrophage-Activating Lipopeptide-2 Activates Immune Cells Through a Toll-Like Receptor 2- and MyD88-Dependent Signaling Pathway1
Osamu Takeuchi; Andreas Kaufmann; Karsten Grote; Taro Kawai; Katsuaki Hoshino; Michael Morr; Peter F. Mühlradt; Shizuo Akira
J Immunol (2000) 164 (2): 554–557.
Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1
J Immunol (2000) 164 (2): 558–561.
Cutting Edge: CD4+ T Cell Control of CD8+ T Cell Reactivity to a Model Tumor Antigen
J Immunol (2000) 164 (2): 562–565.
CELLULAR IMMUNOLOGY AND IMMUNE REGULATION
IFN-α-Expressing Tumor Cells Enhance Generation and Promote Survival of Tumor-Specific CTLs
J Immunol (2000) 164 (2): 567–572.
Presentation of IFN-γ to Nitric Oxide-Producing Cells: A Novel Function for Mast Cells1
J Immunol (2000) 164 (2): 573–579.
Modulation of Th2 Responses by Peptide Analogues in a Murine Model of Allergic Asthma: Amelioration or Deterioration of the Disease Process Depends on the Th1 or Th2 Skewing Characteristics of the Therapeutic Peptide1
Edith M. Janssen; Antoon J. M. van Oosterhout; Annemiek J. M. L. van Rensen; Willem van Eden; Frans P. Nijkamp; Marca H. M. Wauben
J Immunol (2000) 164 (2): 580–588.
HIV-1 gp120 Induces IL-4 and IL-13 Release from Human FcεRI+ Cells Through Interaction with the VH3 Region of IgE1
J Immunol (2000) 164 (2): 589–595.
The Use of HLA A2.1/p53 Peptide Tetramers to Visualize the Impact of Self Tolerance on the TCR Repertoire1
J Immunol (2000) 164 (2): 596–602.
Interaction of Ly-49D+ NK Cells with H-2Dd Target Cells Leads to Dap-12 Phosphorylation and IFN-γ Secretion1
J Immunol (2000) 164 (2): 603–611.
Analysis of the Requirements for the Induction of CD4+ T Cell Alloantigen Hyporesponsiveness by Ex Vivo Anti-CD40 Ligand Antibody1
J Immunol (2000) 164 (2): 612–622.
Characterization of the Roles of TNF Receptor-Associated Factor 6 in CD40-Mediated B Lymphocyte Effector Functions1
J Immunol (2000) 164 (2): 623–630.
Murine CCR9, a Chemokine Receptor for Thymus-Expressed Chemokine That Is Up-Regulated Following Pre-TCR Signaling1
J Immunol (2000) 164 (2): 639–648.
In Vivo CD4+ T Cell Tolerance Induction Versus Priming Is Independent of the Rate and Number of Cell Divisions1
J Immunol (2000) 164 (2): 649–655.
Blockade of CTLA-4 Signals Inhibits Th2-Mediated Murine Chronic Graft-Versus-Host Disease by an Enhanced Expansion of Regulatory CD8+ T Cells1
Jinkyo Sakurai; Junko Ohata; Kiyoshi Saito; Hiroaki Miyajima; Takao Hirano; Takao Kohsaka; Shoji Enomoto; Ko Okumura; Miyuki Azuma
J Immunol (2000) 164 (2): 664–669.
Vanadate Induces Calcium Signaling, Ca2+ Release-Activated Ca2+ Channel Activation, and Gene Expression in T Lymphocytes and RBL-2H3 Mast Cells Via Thiol Oxidation1
George R. Ehring; Hubert H. Kerschbaum; Christopher M. Fanger; Claudia Eder; Heiko Rauer; Michael D. Cahalan
J Immunol (2000) 164 (2): 679–687.
Resting B Lymphocytes as APC for Naive T Lymphocytes: Dependence on CD40 Ligand/CD401
J Immunol (2000) 164 (2): 688–697.
Vaccination with Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity1
Alfonso Martín-Fontecha; Monica Moro; Maria Cristina Crosti; Fabrizio Veglia; Giulia Casorati; Paolo Dellabona
J Immunol (2000) 164 (2): 698–704.
Hierarchical Costimulator Thresholds for Distinct Immune Responses: Application of a Novel Two-Step Fc Fusion Protein Transfer Method1
J Immunol (2000) 164 (2): 705–711.
Soluble Antigen and CD40 Triggering Are Sufficient to Induce Primary and Memory Cytotoxic T Cells1
J Immunol (2000) 164 (2): 725–732.
Defective Expression of the Monocyte Chemotactic Protein-1 Receptor CCR2 in Macrophages Associated with Human Ovarian Carcinoma1
Antonio Sica; Alessandra Saccani; Barbara Bottazzi; Sergio Bernasconi; Paola Allavena; Brancatelli Gaetano; Francesca Fei; Graig LaRosa; Chris Scotton; Frances Balkwill; Alberto Mantovani
J Immunol (2000) 164 (2): 733–738.
Comparative Contribution of CD1 on the Development of CD4+ and CD8+ T Cell Compartments1
J Immunol (2000) 164 (2): 739–745.
α4β1 Integrin/VCAM-1 Interaction Activates αLβ2 Integrin-Mediated Adhesion to ICAM-1 in Human T Cells1
J Immunol (2000) 164 (2): 746–753.
The Multidrug Resistance Protein 1: A Functionally Important Activation Marker for Murine Th1 Cells1
J Immunol (2000) 164 (2): 754–761.
IFN-γ Is Necessary But Not Sufficient for Anti-CD40 Antibody-Mediated Inhibition of the Th2 Response to Schistosoma mansoni Eggs1
J Immunol (2000) 164 (2): 779–785.
Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B1
Hiroshi Watanabe; Gérard Garnier; Antonella Circolo; Rick A. Wetsel; Phil Ruiz; V. Michael Holers; Susan A. Boackle; Harvey R. Colten; Gary S. Gilkeson
J Immunol (2000) 164 (2): 786–794.
MOLECULAR AND STRUCTURAL IMMUNOLOGY
Human Cytomegalovirus Gene Products US3 and US6 Down-Regulate Trophoblast Class I MHC Molecules1
J Immunol (2000) 164 (2): 805–811.
Human CD8β, But Not Mouse CD8β, Can Be Expressed in the Absence of CD8α as a ββ Homodimer1
J Immunol (2000) 164 (2): 833–838.
Disparate Intracellular Processing of Human IL-12 Preprotein Subunits: Atypical Processing of the P35 Signal Peptide1
J Immunol (2000) 164 (2): 839–847.
TNF-α Regulates Transforming Growth Factor-α Expression in Regenerating Murine Liver and Isolated Hepatocytes
J Immunol (2000) 164 (2): 872–878.
Transgenic Expression of Ly-49A in Thymocytes Alters Repertoire Selection1
J Immunol (2000) 164 (2): 884–892.
Frequency and Characterization of Phenotypic Ig Heavy Chain Allelically Included IgM-Expressing B Cells in Mice1
J Immunol (2000) 164 (2): 893–899.
Extension of HLA-A*0201-Restricted Minimal Epitope by Nε-Palmitoyl-lysine Increases the Life Span of Functional Presentation to Cytotoxic T Cells1
Estelle Loing; Muriel Andrieu; Kader Thiam; Dominik Schörner; Karl-Heinz Wiesmüller; Anne Hosmalin; Günther Jung; Hélène Gras-Masse
J Immunol (2000) 164 (2): 900–907.
HOST DEFENSE
Type 1 and Type 2 CD8+ Effector T Cell Subpopulations Promote Long-Term Tumor Immunity and Protection to Progressively Growing Tumor1
J Immunol (2000) 164 (2): 916–925.
Decreased Cytomegalovirus Expression Following Proinflammatory Cytokine Treatment of Primary Human Astrocytes1
J Immunol (2000) 164 (2): 926–933.
Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1
J Immunol (2000) 164 (2): 944–953.
Ebola Virus Secretory Glycoprotein (sGP) Diminishes FcγRIIIB-to-CR3 Proximity on Neutrophils1
J Immunol (2000) 164 (2): 953–958.
Characterization of CD4+ T Cell Responses During Natural Infection with Salmonella typhimurium1
J Immunol (2000) 164 (2): 986–993.
Compartmental Differences in NK Cell Responsiveness to IL-12 During Lymphocytic Choriomeningitis Virus Infection1
J Immunol (2000) 164 (2): 994–1001.
INFLAMMATION
Vδ Repertoire During Thymic Ontogeny Suggests Three Novel Waves of γδ TCR Expression
J Immunol (2000) 164 (2): 1002–1012.
Inosine Inhibits Inflammatory Cytokine Production by a Posttranscriptional Mechanism and Protects Against Endotoxin-Induced Shock1
György Haskó; David G. Kuhel; Zoltán H. Németh; Jon G. Mabley; Robert F. Stachlewitz; László Virág; Zsolt Lohinai; Garry J. Southan; Andrew L. Salzman; Csaba Szabó
J Immunol (2000) 164 (2): 1013–1019.
Cyclooxygenase-2-Derived Prostaglandin E2 and Lipoxin A4 Accelerate Resolution of Allergic Edema in Angiostrongylus costaricensis-Infected Rats: Relationship with Concurrent Eosinophilia1
Christianne Bandeira-Melo; Magda F. Serra; Bruno L. Diaz; Renato S. B. Cordeiro; Patricia M. R. Silva; Henrique L. Lenzi; Y. S. Bakhle; Charles N. Serhan; Marco A. Martins
J Immunol (2000) 164 (2): 1029–1036.
Macrophage Inflammatory Protein-2 Is a Mediator of Polymorphonuclear Neutrophil Influx in Ocular Bacterial Infection1
J Immunol (2000) 164 (2): 1037–1045.
Activation of Peroxisome Proliferator-Activated Receptor γ Does Not Inhibit IL-6 or TNF-α Responses of Macrophages to Lipopolysaccharide In Vitro or In Vivo
Rolf Thieringer; Judy E. Fenyk-Melody; Cheryl B. Le Grand; Beverly A. Shelton; Patricia A. Detmers; Elizabeth P. Somers; Linda Carbin; David E. Moller; Samuel D. Wright; Joel Berger
J Immunol (2000) 164 (2): 1046–1054.
A Codominant Role of FcγRI/III and C5aR in the Reverse Arthus Reaction1
Ulrich Baumann; Jörg Köhl; Thomas Tschernig; Kirsten Schwerter-Strumpf; J. Sjef Verbeek; Reinhold E. Schmidt; J. Engelbert Gessner
J Immunol (2000) 164 (2): 1065–1070.
Glomerular Deposition of Immune Complexes Made with IgG2a Monoclonal Antibodies1
J Immunol (2000) 164 (2): 1071–1077.
Soluble IL-4 Receptor Inhibits Airway Inflammation Following Allergen Challenge in a Mouse Model of Asthma1
J Immunol (2000) 164 (2): 1086–1095.
Differential Roles of IL-18 in Allergic Airway Disease: Induction of Eotaxin by Resident Cell Populations Exacerbates Eosinophil Accumulation1
J Immunol (2000) 164 (2): 1096–1102.
CLINICAL IMMUNOLOGY
Myelin-Associated Oligodendrocytic Basic Protein: Identification of an Encephalitogenic Epitope and Association with Multiple Sclerosis1
J Immunol (2000) 164 (2): 1103–1109.
Therapeutic Potential of Phosphodiesterase-4 and -3 Inhibitors in Th1-Mediated Autoimmune Diseases
J Immunol (2000) 164 (2): 1117–1124.
Induction of Potent Antitumor CTL Responses by Recombinant Vaccinia Encoding a Melan-A Peptide Analogue
Danila Valmori; Frederic Lévy; Isabelle Miconnet; Paul Zajac; Giulio C. Spagnoli; Donata Rimoldi; Danielle Liénard; Vincenzo Cerundolo; Jean-Charles Cerottini; Pedro Romero
J Immunol (2000) 164 (2): 1125–1131.
-
Cover Image
Cover Image
Advertisement
Advertisement